

Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.
The global Artificial Intelligence Eye Screening Software market size is projected to grow from US$ 222 million in 2024 to US$ 9536 million in 2030; it is expected to grow at a CAGR of 87.1% from 2024 to 2030.
The “Artificial Intelligence Eye Screening Software Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Eye Screening Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Eye Screening Software sales for 2023 through 2029. With Artificial Intelligence Eye Screening Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Eye Screening Software industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Eye Screening Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Eye Screening Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Eye Screening Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Eye Screening Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Eye Screening Software.
Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy. It is estimated that vision-threatening diabetic retinopathy (vtDR) is present in around 22% of patients with diabetes, with clinically significant macular edema present in about 4% of patients, although the numbers can widely vary based on the population and access to care. Regardless of the exact numbers, there is no doubt that diabetic retinopathy remains a significant health burden and cause of visual loss. Early detection of diabetic retinopathy is key, because early treatment and lifestyle modifications can help prevent or minimize vision-threatening complications.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Eye Screening Software market by product type, application, key players and key regions and countries.
Segmentation by Type:
Diabetic Retinopathy (DR)
Age-Related Macular Degeneration (AMD)
Myopia
Others
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Diabetic Retinopathy (DR)
Age-Related Macular Degeneration (AMD)
Myopia
Others
Segmentation by Application:
Medical Institutions
Great Health Scene
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Eye Screening Software Market Size 2019-2030
2.1.2 Artificial Intelligence Eye Screening Software Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Artificial Intelligence Eye Screening Software by Country/Region, 2019, 2023 & 2030
2.2 Artificial Intelligence Eye Screening Software Segment by Type
2.2.1 Diabetic Retinopathy (DR)
2.2.2 Age-Related Macular Degeneration (AMD)
2.2.3 Myopia
2.2.4 Others
2.3 Artificial Intelligence Eye Screening Software Market Size by Type
2.3.1 Artificial Intelligence Eye Screening Software Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Artificial Intelligence Eye Screening Software Market Size Market Share by Type (2019-2024)
2.4 Artificial Intelligence Eye Screening Software Segment by Application
2.4.1 Medical Institutions
2.4.2 Great Health Scene
2.5 Artificial Intelligence Eye Screening Software Market Size by Application
2.5.1 Artificial Intelligence Eye Screening Software Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Artificial Intelligence Eye Screening Software Market Size Market Share by Application (2019-2024)
3 Artificial Intelligence Eye Screening Software Market Size by Player
3.1 Artificial Intelligence Eye Screening Software Market Size Market Share by Player
3.1.1 Global Artificial Intelligence Eye Screening Software Revenue by Player (2019-2024)
3.1.2 Global Artificial Intelligence Eye Screening Software Revenue Market Share by Player (2019-2024)
3.2 Global Artificial Intelligence Eye Screening Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Artificial Intelligence Eye Screening Software by Region
4.1 Artificial Intelligence Eye Screening Software Market Size by Region (2019-2024)
4.2 Global Artificial Intelligence Eye Screening Software Annual Revenue by Country/Region (2019-2024)
4.3 Americas Artificial Intelligence Eye Screening Software Market Size Growth (2019-2024)
4.4 APAC Artificial Intelligence Eye Screening Software Market Size Growth (2019-2024)
4.5 Europe Artificial Intelligence Eye Screening Software Market Size Growth (2019-2024)
4.6 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size Growth (2019-2024)
5 Americas
5.1 Americas Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
5.2 Americas Artificial Intelligence Eye Screening Software Market Size by Type (2019-2024)
5.3 Americas Artificial Intelligence Eye Screening Software Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Eye Screening Software Market Size by Region (2019-2024)
6.2 APAC Artificial Intelligence Eye Screening Software Market Size by Type (2019-2024)
6.3 APAC Artificial Intelligence Eye Screening Software Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Artificial Intelligence Eye Screening Software Market Size by Country (2019-2024)
7.2 Europe Artificial Intelligence Eye Screening Software Market Size by Type (2019-2024)
7.3 Europe Artificial Intelligence Eye Screening Software Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Artificial Intelligence Eye Screening Software by Region (2019-2024)
8.2 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Type (2019-2024)
8.3 Middle East & Africa Artificial Intelligence Eye Screening Software Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Artificial Intelligence Eye Screening Software Market Forecast
10.1 Global Artificial Intelligence Eye Screening Software Forecast by Region (2025-2030)
10.1.1 Global Artificial Intelligence Eye Screening Software Forecast by Region (2025-2030)
10.1.2 Americas Artificial Intelligence Eye Screening Software Forecast
10.1.3 APAC Artificial Intelligence Eye Screening Software Forecast
10.1.4 Europe Artificial Intelligence Eye Screening Software Forecast
10.1.5 Middle East & Africa Artificial Intelligence Eye Screening Software Forecast
10.2 Americas Artificial Intelligence Eye Screening Software Forecast by Country (2025-2030)
10.2.1 United States Market Artificial Intelligence Eye Screening Software Forecast
10.2.2 Canada Market Artificial Intelligence Eye Screening Software Forecast
10.2.3 Mexico Market Artificial Intelligence Eye Screening Software Forecast
10.2.4 Brazil Market Artificial Intelligence Eye Screening Software Forecast
10.3 APAC Artificial Intelligence Eye Screening Software Forecast by Region (2025-2030)
10.3.1 China Artificial Intelligence Eye Screening Software Market Forecast
10.3.2 Japan Market Artificial Intelligence Eye Screening Software Forecast
10.3.3 Korea Market Artificial Intelligence Eye Screening Software Forecast
10.3.4 Southeast Asia Market Artificial Intelligence Eye Screening Software Forecast
10.3.5 India Market Artificial Intelligence Eye Screening Software Forecast
10.3.6 Australia Market Artificial Intelligence Eye Screening Software Forecast
10.4 Europe Artificial Intelligence Eye Screening Software Forecast by Country (2025-2030)
10.4.1 Germany Market Artificial Intelligence Eye Screening Software Forecast
10.4.2 France Market Artificial Intelligence Eye Screening Software Forecast
10.4.3 UK Market Artificial Intelligence Eye Screening Software Forecast
10.4.4 Italy Market Artificial Intelligence Eye Screening Software Forecast
10.4.5 Russia Market Artificial Intelligence Eye Screening Software Forecast
10.5 Middle East & Africa Artificial Intelligence Eye Screening Software Forecast by Region (2025-2030)
10.5.1 Egypt Market Artificial Intelligence Eye Screening Software Forecast
10.5.2 South Africa Market Artificial Intelligence Eye Screening Software Forecast
10.5.3 Israel Market Artificial Intelligence Eye Screening Software Forecast
10.5.4 Turkey Market Artificial Intelligence Eye Screening Software Forecast
10.6 Global Artificial Intelligence Eye Screening Software Forecast by Type (2025-2030)
10.7 Global Artificial Intelligence Eye Screening Software Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Artificial Intelligence Eye Screening Software Forecast
11 Key Players Analysis
11.1 Airdoc Technology
11.1.1 Airdoc Technology Company Information
11.1.2 Airdoc Technology Artificial Intelligence Eye Screening Software Product Offered
11.1.3 Airdoc Technology Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Airdoc Technology Main Business Overview
11.1.5 Airdoc Technology Latest Developments
11.2 Digital Diagnostics
11.2.1 Digital Diagnostics Company Information
11.2.2 Digital Diagnostics Artificial Intelligence Eye Screening Software Product Offered
11.2.3 Digital Diagnostics Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Digital Diagnostics Main Business Overview
11.2.5 Digital Diagnostics Latest Developments
11.3 Eyenuk
11.3.1 Eyenuk Company Information
11.3.2 Eyenuk Artificial Intelligence Eye Screening Software Product Offered
11.3.3 Eyenuk Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eyenuk Main Business Overview
11.3.5 Eyenuk Latest Developments
11.4 RetinaLyze System
11.4.1 RetinaLyze System Company Information
11.4.2 RetinaLyze System Artificial Intelligence Eye Screening Software Product Offered
11.4.3 RetinaLyze System Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 RetinaLyze System Main Business Overview
11.4.5 RetinaLyze System Latest Developments
11.5 Optomed
11.5.1 Optomed Company Information
11.5.2 Optomed Artificial Intelligence Eye Screening Software Product Offered
11.5.3 Optomed Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Optomed Main Business Overview
11.5.5 Optomed Latest Developments
11.6 Sibionics Technology
11.6.1 Sibionics Technology Company Information
11.6.2 Sibionics Technology Artificial Intelligence Eye Screening Software Product Offered
11.6.3 Sibionics Technology Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sibionics Technology Main Business Overview
11.6.5 Sibionics Technology Latest Developments
11.7 Aeye Health
11.7.1 Aeye Health Company Information
11.7.2 Aeye Health Artificial Intelligence Eye Screening Software Product Offered
11.7.3 Aeye Health Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Aeye Health Main Business Overview
11.7.5 Aeye Health Latest Developments
11.8 VUNO
11.8.1 VUNO Company Information
11.8.2 VUNO Artificial Intelligence Eye Screening Software Product Offered
11.8.3 VUNO Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 VUNO Main Business Overview
11.8.5 VUNO Latest Developments
11.9 Medimaging Integrated Solution
11.9.1 Medimaging Integrated Solution Company Information
11.9.2 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Product Offered
11.9.3 Medimaging Integrated Solution Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Medimaging Integrated Solution Main Business Overview
11.9.5 Medimaging Integrated Solution Latest Developments
11.10 EyRIS (SELENA+)
11.10.1 EyRIS (SELENA+) Company Information
11.10.2 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Product Offered
11.10.3 EyRIS (SELENA+) Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 EyRIS (SELENA+) Main Business Overview
11.10.5 EyRIS (SELENA+) Latest Developments
11.11 Vistel
11.11.1 Vistel Company Information
11.11.2 Vistel Artificial Intelligence Eye Screening Software Product Offered
11.11.3 Vistel Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Vistel Main Business Overview
11.11.5 Vistel Latest Developments
11.12 RETINA-AI Health
11.12.1 RETINA-AI Health Company Information
11.12.2 RETINA-AI Health Artificial Intelligence Eye Screening Software Product Offered
11.12.3 RETINA-AI Health Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RETINA-AI Health Main Business Overview
11.12.5 RETINA-AI Health Latest Developments
11.13 Acer Medical
11.13.1 Acer Medical Company Information
11.13.2 Acer Medical Artificial Intelligence Eye Screening Software Product Offered
11.13.3 Acer Medical Artificial Intelligence Eye Screening Software Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Acer Medical Main Business Overview
11.13.5 Acer Medical Latest Developments
12 Research Findings and Conclusion
*If Applicable.